You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博雅生物(300294.SZ):上半年在採的13個單採血漿站共計採集原料血漿215噸,略低於去年同期水平
格隆匯 09-12 14:35

格隆匯9月12日丨博雅生物(300294.SZ)於2023年09月11日參與電話會議,就“公司血漿採集量情況以及全年採漿量預期”,公司回覆稱,2023年上半年,在影響近2個月原料血漿採集的節奏情況下,在採的13個單採血漿站共計採集原料血漿215噸,略低於去年同期水平。

2023年6月,陽城漿站獲得《單採血漿許可證》並於6月29日正式開採。公司充分利用暑期,大力發展新生漿員,通過提升漿站運營管理能力、營造良好的工作和獻漿環境等措施,提升採集能力。2023年7-8月共採集血漿91.3噸,同比增長9.46%,2023年1-8月,累計採集306.3噸,同比增長1.52%,保持正向增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account